Trial NCT04530357
Publication Zakarya K,, EClinicalMedicine, 2021
Primary outcome on the report: 1) solicited adverse reactions within 7 days after each dose; 2) unsolicited adverse events (AEs) for 21 days after each vaccination; 3) geometric mean titres (GMTs) of S-specific antibodies measured on days 21 and 42 after vaccination; 4) GMTs of virus neutralizing antibodies measured on days 21 and 42 after vaccination

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.